the aid library

LIST OPTIONS

Filter

7783

Sort by:

Direction:

Download (1216)

View PDF (2183)

Cholera Guide

Stephen J.McPhee; and Papadakis Maxine The McGraw-Hill Companies (2010)

Adapted from CURRENT Medical Diagnosis & Treatment 2010

Download (582)

View PDF (844)

Antimicrobials use, reistance and containment baseline survey (Ethiopia)

Drug Administration and Control Authority of Ethiopia , et al. (2009) C1

Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug consumers. These coupled with rapid spread of res... more

Download (590)

View PDF (2529)

Management of healthcare workers returning from Ebola-affected areas

European Centre for Disease Prevention and Control (2015) CC2

Infection prevention and control measures for Ebola virus disease

Download (136)

View PDF (1290)

TB financing in East Europe promotes unnecessary hospital admissions: the case of Armenia

Gillini, L.; K. Davtyan, H. Davtyan, et al. (2013) C2

The Journal of Infection in Developing Countries 7(3):289-292

Download (124)

View PDF (841)

Best Practices for Environmental Cleaning in Healthcare Facilities: in Resource-Limited Settings

Centers for Disease Control and Prevention CDC (2019) C_CDC

Healthcare-associated infections (HAI) are a significant burden globally, with millions of patients affected each year. These infections affect both high- and limited-resource healthcare settings, but in limited-resource settings, rates are approximately twice as high as high-resource settings (15 o... more

Download (77)

View PDF (1103)

Factsheet for experts - Antimicrobial resistance

European Centers for Disease Control and Prevention ECDC (2019) CC

Nosocomial infections and antimicrobial resistance are two special health issues listed in Annex 1 of Commission Decision 2000/96/EC of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No 2119/98/EC of the European Parliament and of th... more

Download (73)

View PDF (1043)

The Role of Nursing Homes in the Spread of Antimicrobial Resistance Over the Healthcare Network

van den Dool C., PhD; A. Haenen; T. Leenstra, MD, PhD; et al. (2016) C2

The spread of antimicrobial-resistant microorganisms poses anincreasing threat to affordable modern health care. In the Netherlands, efforts to control the dispersal of known and novel antimicrobial-resistant organisms have been mostly implemented at the hospital level. However, recent studies have ... more

Download (160)

View PDF (208)

Situation Analysis Antibiotic Use and Resistance in India

Public Health Foundation India (2011) C2

The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ... more

Download (342)

View PDF (250)

Résumé des Recommandations de l’OMS pour l’Hygiène des Mains au cours des Soins

World Health Organization WHO (2010) C_WHO

Les infections associées aux soins (IAS) touchent des centaines de millions de patients dans le monde chaque année. Ces infections sont à l’origine de pathologies graves, de prolongements de la durée du séjour en établissement de soins, d’invalidités à long terme, de coûts personnels im... more

Download (91)

View PDF (138)

ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus

Dyar O.J., B. Beovic, C. Pulcini et al. Elsevier (2018) C2

Using antimicrobials responsibly is an essential component ofefforts to contain antimicrobial resistance (AMR), and to ensurethat patients receive appropriate treatment. The WHO global action plan on AMR emphasizes the importance of training healthcare professionals in antimicrobial prescribing and ... more

Download (86)

View PDF (107)

Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols

Kratzel, A.; D. Todt, P. V’kovski, et al. (2020) CC

Emerg Infect Dis. 2020 Jul [date cited]. https://doi.org/10.3201/eid2607.200915 Infection control instructions call for use of alcohol-based hand rub solutions to inactivate severe acute respiratory syndrome coronavirus 2. We determined the virucidal activity of World Health Organization–recommen... more

Download (178)

View PDF (252)

Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level
recommended

World Health Organization WHO (2020) C_WHO

This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention and control of CROs and the Global Action Plan on Antimicrobial Resistance (AMR). It describes how the eight recommendations contained within the World Health ... more

Download (92)

View PDF (125)

Neonatal outcomes of pre-diagnosed COVID-19 positive mothers in Nigeria

B. Ezenwa; Fajolu, I.; Makwe, C.; et al. (2021) CC

COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies exposed in-utero, especially in Africa. The objectiveof this study was to document the perinatal outcomes of COVID-19 pregnancies and del... more

Download (354)

View PDF (297)

Portable digital radiography system: technical specifications

World Health Organization WHO (2021) C_WHO

The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware and software packages listed in the following specifications are described in... more

Download (341)

View PDF (331)

WHO neonatal resuscitation manikin technical specifications

World Health Organization WHO WHO (2021) CC

The United Nations Commission on Life-Saving Commodities (UNCLSC, 2012) defined 13 health products to end preventable deaths of woman and children. One of those 13 products is the neonatal resuscitator, is indispensable medical device to save newborns from asphyxia at birth. For the efficient use of... more

Download (55)

View PDF (830)

Investing in drug-resistant tuberculosis household contact management and preventive treatment

Hussain.H.; Malik, A. A. The Lancet (2022) CC

Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv... more

Download (104)

View PDF (788)

Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas

Suárez, C., Nolder, D., García-Mingo, A. et al. Research and reports in tropical medicine (2022) CC

Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with poverty and stigma. A third of the cases evolve into chronic... more

Download (146)

View PDF (221)

Democratic Republic of Timor-Leste Ministry of Health - Comprehensive TB Guidelines for National Tuberculosis Program, V Edition

Government of Timor-Leste; World Health Organization (2023) CC

The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death. The salient observations are as follows: In 2018, 487 (12.5%) of the... more

Download (140)

View PDF (192)

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

World Health Organization WHO (2023) C_WHO

This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...2021–2030 to attain the Sustainable Development Goals (SDGs) by 2030. The Lao People’s Democratic Republic experienced substantial economic growth in the 30 years prior to the coronavirus disease (COVID-19) pandemic, contributing to reduced poverty and significant progress toward the SDGs. However, the COVID-19 pandemic brought this development to a halt. It was anticipated that the COVID-19 recovery and the tremendous population growth in recent years would provide opportunities for a shift toward more sustainable and inclusive development in the years ahead. In 2023, however, the contrary was the case. Rural residents, including many ethnic minorities, continued to face marginalization because of limited access to education, health care and economic opportunities. Despite the challenges of COVID-19 and other disease outbreaks, the country has made significant improvements in health. Nonetheless, progress has been uneven and not everyone has benefited from these achievements. In the mountainous region, many people lack access to quality health care because of the unequal distribution of well-trained health-care workers. Preventable deaths due to poor-quality health care for children and newborns, infants and mothers remain a concern, as do communicable diseases such as sexually transmitted infections and tuberculosis. The increasing burden of noncommunicable diseases and the health impact of worsening climate change further heighten the need for strengthened and resilient health systems, which are at risk due to an underfunded health sector and weak economy. This CCS aims to address remaining and future challenges as well as health needs while creating an impact that is sustainable. It identifies three strategic priorities and nine deliverables (Table 1) to support the attainment of the national vision of Health for all by all, as articulated in the 9th Health Sector Development Plan 2021–2025. It contributes to the country’s goals to achieve universal health coverage, graduate from least developed country status by 2026 and attain SDGs by 2030. more

Download (115)

View PDF (117)

Recent Advances in the Management Strategies for Buruli Ulcers

Popa G.; Muntean Al., Popa M. (2023) CC

Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.

Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level recommended

Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level
recommended